<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim V</submitter><funding>NIAID NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>e189858</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12288977</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(14)</volume><pubmed_abstract>Cellular metabolism plays a key role in T cell biology. Increased glycolysis and mitochondrial respiration have been identified in CD4+ helper T cells from both patients with systemic lupus erythematosus (SLE) and lupus mouse models. Inhibiting this metabolic activity can reduce T cell activation and ameliorate disease symptoms in lupus mice. However, the metabolic differences among circulating follicular helper T (cTfh) cell subsets in patients with SLE versus healthy controls (HCs) have not been thoroughly studied. While the frequencies of cTfh cells and their subsets were similar between patients with SLE and HCs, patients exhibited a higher proportion of activated ICOS+ programmed cell death 1-positive cells, which correlated with disease activity. cTfh17 cells from both patients with </pubmed_abstract><journal>JCI insight</journal><pubmed_title>Metabolic pathways within cTfh subsets and glucose-dependent activation of cTfh17 in SLE and healthy individuals.</pubmed_title><pmcid>PMC12288977</pmcid><funding_grant_id>U19 AI144306</funding_grant_id><funding_grant_id>R01 AR074565</funding_grant_id><pubmed_authors>Aranow C</pubmed_authors><pubmed_authors>Tian H</pubmed_authors><pubmed_authors>Kim V</pubmed_authors><pubmed_authors>Misao T</pubmed_authors><pubmed_authors>Mackay M</pubmed_authors><pubmed_authors>Kim SJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic pathways within cTfh subsets and glucose-dependent activation of cTfh17 in SLE and healthy individuals.</name><description>Cellular metabolism plays a key role in T cell biology. Increased glycolysis and mitochondrial respiration have been identified in CD4+ helper T cells from both patients with systemic lupus erythematosus (SLE) and lupus mouse models. Inhibiting this metabolic activity can reduce T cell activation and ameliorate disease symptoms in lupus mice. However, the metabolic differences among circulating follicular helper T (cTfh) cell subsets in patients with SLE versus healthy controls (HCs) have not been thoroughly studied. While the frequencies of cTfh cells and their subsets were similar between patients with SLE and HCs, patients exhibited a higher proportion of activated ICOS+ programmed cell death 1-positive cells, which correlated with disease activity. cTfh17 cells from both patients with </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-07-15T14:17:19.855Z</modification><creation>2025-08-27T03:06:49.078Z</creation></dates><accession>S-EPMC12288977</accession><cross_references><pubmed>40693461</pubmed><doi>10.1172/jci.insight.189858</doi></cross_references></HashMap>